Summary for ARTG Entry:
AQUINARETIC 10/12.5 quinapril hydrochloride and hydrochlorothiazide 10/12.5mg tablet blister pack
ARTG entry for
Pfizer Australia Pty Ltd
PO Box 57,WEST RYDE, NSW, 2114
ARTG Start Date
Drug Safety Evaluation Branch
Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods
Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered
or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.
1. AQUINARETIC 10/12.5
Single Medicine Product
See Product Information and Consumer Medicine Information for this product
AQUINARETIC is indicated for the treatment of hypertension. Treatment should not be initiated with these fixed dose combinations.
Additional Product information
Store below 25
Pack Size/Poison information
(S4) Prescription Only Medicine
Tablet, film coated
Route of Administration
A pink oval, biconvex film coated tablet scored on both sides.
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 29.11.2017 at 04:13:15 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information